\-\ Texto\\:\\ \ \(0\)\
\-\ elderly\\ black\\ female\ \(0\)\
\-\ blood\\ pressure\\:\\ \\ 164\\/95\ \(0\)\
\-\ creatinine\\:\\ \\ 1\\.9\ \(0\)\
\-\ palmaz\\ stent\\ placed\\ across\\ ostial\\ stenosis\\ of\\ left\\ renal\\ artery\ \(0\)\
\-\ left\\ renal\\ artery\\ stenosis\\ on\\ mra\ \(0\)\
\-\ \\>\\ 75\\%\\ stenosis\\ of\\ left\\ renal\\ artery\ \(1\)\
\-\ severe\\ stenosis\\ at\\ the\\ ostium\\ of\\ the\\ left\\ renal\\ artery\\ causing\\ renovascular\\ hypetension\\.\ \(1\)\
\-\ renovascular\\ hypertension\ \(2\)\
\-\ renal\\ artery\\ stenosis\\ secondary\\ to\\ atherosclerosis\ \(0\)\
\-\ renal\\ artery\\ stenosis\\ secondary\\ to\\ fibromuscular\\ dysplasia\ \(0\)\
\-\ 84\\ year\\ old\\ female\\ with\\ multiple\\ medical\\ problems\\,\\ including\\ hypertension\\ which\\ is\\ poorly\\ controlled\\ on\\ three\\ medications\\.\ \(1\)\
\-\ notice\\ that\\ the\\ microwire\\ used\\ during\\ stent\\ placement\\ has\\ a\\ curved\\ tip\\.\\ \\ this\\ protects\\ the\\ tertiary\\ branches\\ of\\ the\\ renal\\ artery\\ from\\ perforation\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ stenosis\\:\\ 0\\.4079932442227309\ \(0\)\
\-\ renal\\:\\ 0\\.3896687320776996\ \(0\)\
\-\ artery\\:\\ 0\\.3886289542361256\ \(0\)\
\-\ renovascular\\:\\ 0\\.26419035952721404\ \(0\)\
\-\ stent\\:\\ 0\\.18037815450803807\ \(0\)\
\-\ palmaz\\:\\ 0\\.1429573645598808\ \(0\)\
\-\ ostial\\:\\ 0\\.1429573645598808\ \(0\)\
\-\ hypetension\\:\\ 0\\.1429573645598808\ \(0\)\
\-\ microwire\\:\\ 0\\.1429573645598808\ \(0\)\
\-\ hypertension\\:\\ 0\\.13679461236124765\ \(0\)\
\-\ protects\\:\\ 0\\.12859833730582812\ \(0\)\
\-\ left\\:\\ 0\\.12197432515340792\ \(0\)\
\-\ curved\\:\\ 0\\.12123299496733322\ \(0\)\
\-\ ostium\\:\\ 0\\.11138218172783068\ \(0\)\
\-\ tertiary\\:\\ 0\\.11037081017105942\ \(0\)\
\-\ secondary\\:\\ 0\\.10596985637094183\ \(0\)\
\-\ notice\\:\\ 0\\.10401683938933577\ \(0\)\
\-\ fibromuscular\\:\\ 0\\.10217108262216229\ \(0\)\
\-\ atherosclerosis\\:\\ 0\\.09902640824644626\ \(0\)\
\-\ elderly\\:\\ 0\\.09416602614983323\ \(0\)\
\-\ controlled\\:\\ 0\\.09315465459306198\ \(0\)\
\-\ 84\\:\\ 0\\.09283153345191757\ \(0\)\
\-\ black\\:\\ 0\\.09160181888033252\ \(0\)\
\-\ creatinine\\:\\ 0\\.09102135177411722\ \(0\)\
\-\ the\\:\\ 0\\.08918477525360743\ \(0\)\
\-\ branches\\:\\ 0\\.08864644057851181\ \(0\)\
\-\ mra\\:\\ 0\\.08840347725990824\ \(0\)\
\-\ across\\:\\ 0\\.08701985969374228\ \(0\)\
\-\ female\\:\\ 0\\.08627158391198143\ \(0\)\
\-\ perforation\\:\\ 0\\.08438501623349104\ \(0\)\
\-\ tip\\:\\ 0\\.08401627404079931\ \(0\)\
\-\ poorly\\:\\ 0\\.08073963408405872\ \(0\)\
\-\ 75\\:\\ 0\\.0784086738483484\ \(0\)\
\-\ problems\\:\\ 0\\.07754129246363446\ \(0\)\
\-\ medications\\:\\ 0\\.07498846147059618\ \(0\)\
\-\ causing\\:\\ 0\\.07342982926431488\ \(0\)\
\-\ of\\:\\ 0\\.06997452185245366\ \(0\)\
\-\ placement\\:\\ 0\\.06980370411574482\ \(0\)\
\-\ placed\\:\\ 0\\.0696572467867466\ \(0\)\
\-\ dysplasia\\:\\ 0\\.06846470766147145\ \(0\)\
\-\ pressure\\:\\ 0\\.06806457987819875\ \(0\)\
\-\ used\\:\\ 0\\.06692207098596423\ \(0\)\
\-\ including\\:\\ 0\\.06397338941151087\ \(0\)\
\-\ three\\:\\ 0\\.06000693671176142\ \(0\)\
\-\ medical\\:\\ 0\\.05681223002856428\ \(0\)\
\-\ during\\:\\ 0\\.05662073086176086\ \(0\)\
\-\ severe\\:\\ 0\\.05658904061812232\ \(0\)\
\-\ on\\:\\ 0\\.05399587298693568\ \(0\)\
\-\ blood\\:\\ 0\\.05191549614620779\ \(0\)\
\-\ to\\:\\ 0\\.0446956787866485\ \(0\)\
\-\ multiple\\:\\ 0\\.043723602049180244\ \(0\)\
\-\ has\\:\\ 0\\.040831688316637485\ \(0\)\
\-\ which\\:\\ 0\\.040647459066090304\ \(0\)\
\-\ that\\:\\ 0\\.0387928016746383\ \(0\)\
\-\ from\\:\\ 0\\.03550273638039332\ \(0\)\
\-\ at\\:\\ 0\\.033764512714928197\ \(0\)\
\-\ this\\:\\ 0\\.030716721616201564\ \(0\)\
\-\ year\\:\\ 0\\.02754887289571679\ \(0\)\
\-\ old\\:\\ 0\\.026456454258898757\ \(0\)\
\-\ is\\:\\ 0\\.024480622946176315\ \(0\)\
\-\ with\\:\\ 0\\.017504082903146624\ \(0\)\
